Patent · US Active

Pure heptasulfated disaccharides having improved oral bioavailability

US10829509B2 · kind B2 · utility

0Cited by

5References

4Claims

0Family size

Assignee

OPKO Pharmaceuticals, LLC · US

Inventors

Tahir Ahmed · Kendall, US
Arie Gutman · Haifa, IL
Irina Fedotev · Haifa, IL
Igor Rukhman · Nesher, IL
OLGA GROSSMAN · Shlomi, IL

Key dates

Filing date	Aug 14, 2017
Grant date	Nov 10, 2020
Priority date	—
Expiry date	Aug 14, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Hypersulfated disaccharides with utility in asthma or asthma related disorders are disclosed. The heptasulfated disaccharides administered orally have comparable bioavailability to the intravenous administered dosage form.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.